Londax CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
Londax Corp. files an amendment to its Form 8-K to correct details regarding director resignations and confirm the acquisition of control by Alpha Investment Inc., with Jon S. Cummings IV appointed as CEO.
OTC.Pink
Londax Corp. has announced a change of control with Alpha Investment Inc. acquiring approximately 90% of its common stock, leading to a transition in executive leadership and board composition.
OTC.Pink
Londax Corp. announced significant leadership changes, including new interim CEO and CFO appointments, and the relocation of its principal executive offices to Cyprus, citing cost reduction and efficiency.
OTC.Pink
Londax Corp. announced the appointment of Ms. Ani Vashakidze, a 27-year-old marketing director, as a new director to its Board.
OTC.Pink
A director of Londax Corp. voluntarily cancelled 3 million restricted shares without compensation, significantly reducing the company's total outstanding shares and altering its capital structure.
OTC.Pink
Londax Corp. announced the appointment of Mr. Giorgi Loloshvili, owner of an IT company, as a new director to its Board, effective July 11, 2025.